Assembly Biosciences, Inc. Other Noncash Income (Expense)
Assembly Biosciences, Inc. (ASMB) reported Other Noncash Income (Expense) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2021-02-25
- Assembly Biosciences, Inc. other noncash income (expense) for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. other noncash income (expense) for the quarter ending 2020-09-30 was $0.00.
- Assembly Biosciences, Inc. other noncash income (expense) for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. other noncash income (expense) for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. other noncash income (expense) for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Assembly Biosciences, Inc. other noncash income (expense) for fiscal 2019 was $5.00K.
- Assembly Biosciences, Inc. other noncash income (expense) for fiscal 2018 was $0.00.
- Assembly Biosciences, Inc. other noncash income (expense) for fiscal 2017 was -$615.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $23.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $23.00K derived: sum of 3 quarters · filed 2021-02-25 | $0.00 derived: sum of 4 quarters · filed 2021-02-25 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 | $23.00K derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $4.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $4.00K derived: sum of 3 quarters · filed 2021-02-25 | $5.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$19.00K derived: sum of 2 quarters · filed 2020-11-05 | -$18.00K 10-Q · filed 2020-11-05 | $5.00K 10-Q · filed 2019-11-07 | -$18.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $5.00K 10-Q · filed 2020-08-05 | $5.00K derived: sum of 3 quarters · filed 2021-02-25 | $155.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $1.00K 10-Q · filed 2020-05-08 | $1.00K derived: sum of 2 quarters · filed 2021-02-25 | $151.00K derived: sum of 3 quarters · filed 2021-02-25 | $24.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $150.00K derived: sum of 2 quarters · filed 2021-02-25 | $23.00K derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | |
| 2018-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $23.00K derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$150.00K 10-Q · filed 2019-08-05 | |||
| 2018-03-31 | -$23.00K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$615.00K 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |